SANTA ANA, Calif., June 5 /PRNewswire-FirstCall/ -- Advanced Medical Optics, Inc. (AMO) , today announced that Executive Vice President of Operations; President, Eye Care Business; and Chief Financial Officer; Richard A. Meier, will present an overview of the company at the FTN Midwest Securities 2006 Health Care Conference in New York, on Wednesday, June 7, 2006 at 12:00 p.m. ET.
(Logo: http://www.newscom.com/cgi-bin/prnh/20050324/AMOLOGO )
On June 14, 2006, AMO Chairman, President and Chief Executive Officer, James V. Mazzo, will present at the Goldman Sachs Twenty-Seventh Annual Global Healthcare Conference in Dana Point, California, at 2:20 p.m. PT.
Additionally, Corporate Vice President and Chief Marketing Officer C. Russell Trenary III, will present at the 16th Annual Wachovia Securities Nantucket Equity Conference in Massachusetts, on Wednesday, June 21, 2006, at 8:30 a.m. ET.
To access audio webcasts of these presentations, please visit AMO's Investors site at http://www.amo-inc.com.
About Advanced Medical Optics (AMO)
AMO is a global medical device leader focused on the discovery and delivery of innovative vision technologies that optimize the quality of life for people of all ages. Products in the ophthalmic surgical line include intraocular lenses, laser vision correction systems, phacoemulsification systems, viscoelastics, microkeratomes and related products used in cataract and refractive surgery. AMO owns or has the rights to such ophthalmic surgical product brands as ReZoom(TM), Clariflex(R), Sensar(R), CeeOn(R), Tecnis(R) and Verisyse(TM) intraocular lenses, STAR S4 IR(TM) laser vision correction system, WaveScan Wavefront(R) System, CustomVue(TM) procedure, Sovereign(R) and Sovereign(R) Compact(TM) phacoemulsification systems with WhiteStar(R) technology, Amadeus(TM) and Amadeus(TM) II microkeratomes, Healon(R) viscoelastics, and the Baerveldt(R) glaucoma shunt. Products in the contact lens care line include disinfecting solutions, enzymatic cleaners and lens rewetting drops. Among the eye care product brands the company possesses are COMPLETE(R) Moisture PLUS(TM), COMPLETE(R) Blink-N-Clean(R), Consept(R)F, Consept(R) 1 Step, Oxysept(R) 1 Step, UltraCare(R), Ultrazyme(R), Total Care(TM) and blink(TM) branded products. Amadeus is a licensed product of, and a trademark of, SIS, Ltd. AMO is based in Santa Ana, California, and employs approximately 3,600 worldwide. The company has operations in 24 countries and markets products in approximately 60 countries. For more information, visit the company's Web site at www.amo-inc.com.
Investor Contact: Erika Richmond (714) 247-8348 erika.richmond@amo-inc.com
Photo: NewsCom: http://www.newscom.com/cgi-bin/prnh/20050324/AMOLOGOAP Archive: http://photoarchive.ap.orgPRN Photo Desk, photodesk@prnewswire.comAdvanced Medical Optics, Inc.CONTACT: Investors, Erika Richmond of Advanced Medical Optics, Inc.,+1-714-247-8348, erika.richmond@amo-inc.com
Web site: http://www.amo-inc.com/
